$1.57
At close: May 7 EDT
$1.52
-0.05-3.18%
Pre-Market: 7:41 PM EDT
Comments
Loading...
Galectin Therapeutics Stock Guidance | NASDAQ:GALT | Benzinga
Galectin Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Galectin Therapeutics (GALT)?
There have been no specific sales or earnings guidance reported for Galectin Therapeutics in recent months.
Browse guidance and forecast on all stocks.
